Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04LCQ
|
||||
| Former ID |
DNAP001264
|
||||
| Drug Name |
Tafluprost
|
||||
| Synonyms |
Zioptan (TN)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
Merck
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C25H34F2O5
|
||||
| InChI |
InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1
|
||||
| InChIKey |
WSNODXPBBALQOF-VEJSHDCNSA-N
|
||||
| CAS Number |
CAS 209860-87-7
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
14833400, 16479496, 22395198, 24159835, 45290755, 47207932, 51701855, 58832503, 126666556, 135262832, 136926196, 137248721, 139498527, 142864543, 160645612, 162200065, 174549070, 175268334, 175427102, 187051754, 198993062, 210279761, 210282084, 223663993, 227511615, 251916091, 251917439, 252216358, 252457570, 252815367
|
||||
| ChEBI ID |
ChEBI:66899
|
||||
| SuperDrug ATC ID |
S01EE05
|
||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin F2-alpha receptor | Target Info | Modulator | [551871] | |
| References | |||||
| Ref 530618 | Mol Endocrinol. 2010 Feb;24(2):436-46. Epub 2010 Jan 5.Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation. | ||||
| Ref 532210 | Nat Rev Drug Discov. 2013 Feb;12(2):87-90. | ||||
| Ref 542476 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7451). | ||||
| Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.